[The carcinoembryonic antigen (CEA) in bronchial carcinoma before and after operation (author's transl)].
In 53 p.c. of 175 patients with bronchial carcinoma the carcinoembryonic antigen (CEA) was elevated at the time of diagnosis. In patients with small well bordered tumors (T 1/2) 31 p.c. proved pathological CEA-values in comparison to 80 p.c. in patients with heamatogenic metastases. After radical tumor resection (36 patients) elevated CEA-levels returned to normal ranges within 5 weeks. No decrease could be observed after palliative operations (16 patients). If there existed haematogenic metastases normal CEA-values increased postoperative. Such an increase occured up to ten weeks before metastases could be found by other methods. In cases of bronchial carcinoma CEA-measurements are usefull to evaluate the effect of operation and in the follow up time. It should be carried out on principle in those patients which can be considered for a surgical therapy.
D001984:Bronchial Neoplasms / Q000097:blood* / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005500:Follow-Up Studies; D006801:Humans; D010166:Palliative Care; D011182:Postoperative Care; D011300:Preoperative Care; D013997:Time Factors
D002272:Carcinoembryonic Antigen
Das karzinoembryonale Antigen (CEA) vor und nach Operationen von Bronchialkarzinomen.